Scatena, R <br/><br/>
Bivalirudin: a new generation antithrombotic drug.  [electronic resource] 

 -  Expert opinion on investigational drugs  May 2000 
 - 1119-27 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1354-3784 
<br/><br/><label>Standard No.: </label>10.1517/13543784.9.5.1119  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Coronary Disease--drug therapy<br/>Drug Approval<br/>Fibrinolytic Agents--adverse effects<br/>Hirudin Therapy<br/>Hirudins--adverse effects<br/>Humans<br/>Peptide Fragments--adverse effects<br/>Recombinant Proteins--adverse effects